ABOUT THIS STUDY
- Is male or female 2 years and older at the Screening visit/time of informed consent/assent diagnosed with mild-moderate AD (according to the criteria of Hanifin and Rajka), of at least 5% BSA.
- Has any clinically significant medical disorder, condition, or disease (including
active or potentially recurrent non AD dermatological conditions and known genetic
dermatological conditions that overlap with AD, such as Netherton syndrome) or
clinically significant physical examination finding at Screening that in the PI's or
designee's opinion may interfere with study objectives.
- Has participated in a previous crisaborole clinical study.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Chicago, Illinois
- Charleston, South Carolina
- Boston, Massachusetts